A new generation of cancer treatments are utilising the power of the human immune system to fight the disease
Clinical trials have begun for the world’s first mRNA lung cancer vaccine, marking a ‘new dawn in cancer treatment’
The newly tested blinatumomab precisely targets the cancer cells, offering a kinder alternative to chemotherapy, which damages normal cells in the body and leads to serious side effects.
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
